Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 3/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.37 |
| ▸ | NOD2 | Q9HC29 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL20874361 | 1.00 | GLO1 (0.40) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874381 | 0.96 | GLO1 (0.40) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874380 | 0.96 | GLO1 (0.40) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874291 | 0.93 | GLO1 (0.42) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874292 | 0.93 | GLO1 (0.42) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874213 | 0.91 | GLO1 (0.41) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874216 | 0.91 | GLO1 (0.41) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874260 | 0.91 | GLO1 (0.43) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874263 | 0.91 | GLO1 (0.43) | GLO1NOD1NOD2ALDH1A1POLB | |
| Bromide SCHEMBL20874275 | 0.90 | TLR7 (0.38) | GLO1PTGS1GSTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3468563-B1 | COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME | UNIV OREGON STATE (US) | 2023-09-13 | — | — | EP | disclosed |
| US-20190106456-A1 | COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME | OREGON STATE UNIVERSITY (US) | 2019-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106456-A1 | COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME | GSR, TXN2, GLS | GLO1 106/4885NOD1 3585/4885NOD2 2227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.